el uso de vasopresina o sus análogos frente a catecolaminas solas norepinefrina, dopamina o placebo entre pacientes con shock séptico no mostro resultados favorables en mortalidad con incidencia de isquemia digital mayor https://t.co/PBzRSiDCzx
RT @FrontPharmacol: New Research: Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients Wit…
New Research: Clinical Efficiency of Vasopressin or Its Analogs in Comparison With Catecholamines Alone on Patients With Septic Shock: A Systematic Review and Meta-Analysis https://t.co/AoVypzUhPZ #pharmacology
RT @Links_Medicus: Meta-Analysis: Vasopressin or Its Analogs are Not Associated with Reduced Mortality Compared to Catecholamines Alone in…